Publications:
Jezek J, Chen D, Watson L, Crawford J, Perkins S, Tyagi A, Jones-Braun L.
A heat-stable hepatitis B vaccine formulation. Human Vaccines (2009),
5(8), 529-35.
Jones-Braun L, Jezek J, Peterson S, Tyagi A, Perkins S, Sylvester D, Guy M,
Lal M, Priddy S, Plzak H, Kristensen D, Chen D. Characterization of a
thermostable hepatitis B vaccine formulation. Vaccine (2009), 27, 4609-14.
Selected posters:
BioProcess International, Dusseldorf, Germany (April 2009): Superior stability
of biological molecules can be achieved in unconventional formulations.
BioProcess International, Raleigh, USA (October 2009): Reformulation of existing
protein therapeutics to minimize aggregation and improve their stability.
PEPTalk, San Diego, USA (January 2010): Reformulation of existing protein
therapeutics to minimize aggregation and improve their stability.
BioProcess International, Vienna, Austria (May 2010): Novel formulations of
protein biologics with considerably reduced rate of aggregation.